Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Guideline Adherence Required to Address Pediatric Constipation
• Science, Concerns Behind the MiraLAX Laxative Debate Ashish S. Chogle, MD
• Crohn’s MAP Antibiotic Trial Results Expected Early
• Janssen Licenses Two IBD Drug Candidates to New Biopharma Company
• Microbiome Therapy Shows Benefit in Ulcerative Colitis
• Pediatric Constipation Presents with Added Levels of Complex Care Edward V. Loftus Jr., MD
• IBD: Creating a Clearer Picture of a Fuzzy Disease
• AASLD, IDSA Update HCV Guidance for Resistance, New Drug Approvals
• AGA Provides Guidance on Managing GI Side Effects of Opioids
• Antibiotic Use, C. difficile Increase Under Electronic Sepsis Protocol
• Individualized IBS Diets Reduce Symptoms Better Than Placebo
• ‘Mycobiome’ Research Suggests Antifungals, Probiotics Could Treat Crohn’s Disease
• Patient Handwashing Cuts C. difficile Rate in Hospital
• Hospice Care May Come too Late for Patients With Chronic Liver Disease
• Tryptophan Deficiency Linked to IBD Development
• ACG President: We are ‘Moving the Needle’ on MOC
• Bariatric Surgery Patients at Risk for Alcohol Abuse
• Most Dietary Supplements Mislabeled, May Cause Liver Injury
• Novel Blood Test Accurately Assesses Mucosal Healing Across Crohn’s Subtypes
• Serrated Polyps Plus High-risk Adenomas Increase Colon Cancer Risk
• Surgeon General: We Will Conquer HCV, Opioids ‘One Bite at a Time’
• Tenofovir Exalidex Safe, Well-tolerated in Early HBV Trial
• TOUCHSTONE: 2-Year Data Support Phase 3 Trial of Ozanimod in UC
• Vibrating Capsule Relieves Chronic Idiopathic Constipation
• GI Nutrition Conference Highlights Latest in Diet Therapies, Microbiome, Telemedicine
• Hypnosis for Gut Disorders: Addressing the Brain-gut Connection